{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:44:58Z","timestamp":1773337498859,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"19-20","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.cca.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T16:03:29Z","timestamp":1337184209000},"page":"1652-1656","source":"Crossref","is-referenced-by-count":31,"title":["Serum interleukin\u20106 levels in response to methotrexate treatment in psoriatic patients"],"prefix":"10.1016","volume":"413","author":[{"given":"Tamilselvi","family":"Elango","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haripriya","family":"Dayalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapna","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpa","family":"Gnanaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemamalini","family":"Malligarjunan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2012.05.007_bb0270","author":"National Psoriasis Foundation"},{"key":"10.1016\/j.cca.2012.05.007_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis \u2013 recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0015","first-page":"111","article-title":"Cytokine network in psoriasis. Cross-talk between keratinocytes and cells of the skin immune system","volume":"31","author":"Wojas-Pelc","year":"2006","journal-title":"Centr Eur J Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08830189809042997","article-title":"Interleukin 6 and its receptor: ten years later","volume":"16","author":"Hirano","year":"1998","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0025","series-title":"Cytokine Reference, 1","first-page":"523","article-title":"IL-6 ligand and receptor family","author":"Hirano","year":"2001"},{"key":"10.1016\/j.cca.2012.05.007_bb0280","first-page":"115","article-title":"IL-8, IL-6 levels and IL-6R in the blood of psoriasis vulgaris patients","volume":"86","author":"Pietrzak","year":"1999","journal-title":"Przegl Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","article-title":"Invited critical review: Cytokines and anticytokines in psoriasis","volume":"394","author":"Pietrzak","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2012.05.007_bb0285","first-page":"80","volume":"5\u20136","author":"Koliadenko","year":"2005","journal-title":"Lik Sprava"},{"key":"10.1016\/j.cca.2012.05.007_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/MI\/2006\/81767","article-title":"Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis","author":"Zalewska","year":"2006","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cca.2012.05.007_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1749-6632.1989.tb24038.x","article-title":"Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity","volume":"557","author":"Kupper","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2012.05.007_bb0055","first-page":"1","article-title":"Regulation of the acute phase and immune responses: interleukin-6","volume":"557","author":"Sehgal","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2012.05.007_bb0060","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.142.7.2321","article-title":"Endotoxemia elicits increased circulating beta 2-IFN\/IL-6 in man","volume":"142","author":"Fong","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0065","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.142.3.948","article-title":"Multiple forms of IFN-beta 2\/IL-6 in serum and body fluids during acute bacterial infection","volume":"142","author":"Helfgott","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00403-010-1033-8","article-title":"Involvement of IL-17F via the induction of IL-6 in psoriasis","volume":"302","author":"Fujishima","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cca.2012.05.007_bb0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0190-9622(88)80237-8","article-title":"Methotrexate in psoriasis. Revised guidelines","volume":"19","author":"Roenigk","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1523-1747.ep12612745","article-title":"Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate","volume":"104","author":"Jeffes","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00011-005-1355-8","article-title":"Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines","volume":"54","author":"Herman","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cca.2012.05.007_bb0090","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2012.05.007_bb0095","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.4049\/jimmunol.165.7.4076","article-title":"Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells","volume":"165","author":"Bonish","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2249.2001.01688.x","article-title":"The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease","volume":"126","author":"Sigmundsdottir","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.cca.2012.05.007_bb0300","first-page":"04101r","article-title":"Methotrexate in psoriasis: from A to Z","volume":"4","author":"Saleh","year":"2010","journal-title":"J Turk Acad Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1073\/pnas.89.2.594","article-title":"Methotrexate induces differentiation of human keratinocytes","volume":"89","author":"Schwartz","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2012.05.007_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.0906-6705.2004.00113.x","article-title":"Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM \u22121, in bullous pemphigoid during methotrexate therapy","volume":"13","author":"Dahlman-Ghozlan","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00403-005-0602-8","article-title":"The changes in expression of ICAM \u22123, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment","volume":"297","author":"Yazici","year":"2005","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.cca.2012.05.007_bb0125","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.cca.2012.05.007_bb0305","first-page":"423","article-title":"Biochemical significance of proinflammatory cytokines in Psoriasis vulgaris among Egyptian Patients","volume":"6","author":"Ragab","year":"2010","journal-title":"J Am Sci"},{"issue":"12","key":"10.1016\/j.cca.2012.05.007_bb0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1309\/T0FJYP2RBXEHX4","article-title":"Evaluation of the performance of the Sysmex XT-2000i Hematolog analyzer with whole bloods stored at room temperature","volume":"40","author":"Valerie","year":"2009","journal-title":"Lab Med"},{"key":"10.1016\/j.cca.2012.05.007_bb0140","series-title":"Fundamentals of clinical chemistry","first-page":"351","article-title":"Carbohydrates","author":"Sacks","year":"1996"},{"key":"10.1016\/j.cca.2012.05.007_bb0310","first-page":"1838","article-title":"Tietz textbook of clinical chemistry","year":"1999"},{"key":"10.1016\/j.cca.2012.05.007_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.24.3.285","article-title":"Serum uric acid estimation-chemical and enzymatic methods compared","volume":"25","author":"Buchanan","year":"1965","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.cca.2012.05.007_bb0315","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinchem\/26.5.551","article-title":"Kinetic serum creatinine assays I. The role of various factors in determining specificity","volume":"26","author":"Bowers","year":"1980","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2012.05.007_bb0160","first-page":"113","article-title":"Selected methods for the small clinical chemistry laboratory","volume":"9","author":"Faulkner","year":"1982","journal-title":"American Association for Clinical Chemistry, Inc."},{"key":"10.1016\/j.cca.2012.05.007_bb0320","first-page":"565","article-title":"Methods of enzymatic analysis","author":"Bergemeyer","year":"1974"},{"key":"10.1016\/j.cca.2012.05.007_bb0325","series-title":"Laboratory tests and diagnostic procedures","author":"Chernecky","year":"2004"},{"issue":"9","key":"10.1016\/j.cca.2012.05.007_bb0330","first-page":"711","article-title":"The role of existing and novel cardiac biomarkers for cardioprotection","volume":"8","author":"Gaze","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.cca.2012.05.007_bb0335","series-title":"The quality of diagnostic samples","first-page":"30","author":"Guder","year":"2001"},{"key":"10.1016\/j.cca.2012.05.007_bb0340","series-title":"Analytical chemistry: an introduction","first-page":"594","article-title":"Flame photometric determination (Chapter 23)","author":"Skoog","year":"2005"},{"issue":"6","key":"10.1016\/j.cca.2012.05.007_bb0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"6 Suppl","key":"10.1016\/j.cca.2012.05.007_bb0195","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12874963","article-title":"Interleukin-6: molecular pathophysiology","volume":"94","author":"Sehgal","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"5","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cca.2012.05.007_bb0205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2230.2000.00727.x","article-title":"Increased interleukin-7 levels in the sera of psoriatic patients: lack of correlations with interleukin-6 levels and disease intensity","volume":"25","author":"Szepietowski","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cca.2012.05.007_bb0210","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory t cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0215","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.0501959102","article-title":"STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2012.05.007_bb0345","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.939.65.3","article-title":"Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2012.05.007_bb0225","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","article-title":"IL-21 counteracts the regulatory T cell mediated suppression of human CD4 T lymphocytes","volume":"178","author":"Peluso","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02593914","article-title":"Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients","volume":"24","author":"Bonifati","year":"1994","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.cca.2012.05.007_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00011-005-1355-8","article-title":"Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines","volume":"54","author":"Herman","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cca.2012.05.007_bb0240","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2133.2003.05407.x","article-title":"Methotrexate inhibits proliferation and regulation of the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by cultured human umbilical vein endothelial cells","volume":"149","author":"Yamasaki","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.cca.2012.05.007_bb0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","article-title":"The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules","volume":"114","author":"Johnston","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cca.2012.05.007_bb0250","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/34.7.602","article-title":"Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells","volume":"34","author":"Seitz","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.cca.2012.05.007_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0923-1811(96)00562-2","article-title":"Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments","volume":"14","author":"Mizutani","year":"1997","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cca.2012.05.007_bb0260","first-page":"89","article-title":"Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low dose methotrexate treatment in rheumatoid arthritis","volume":"64","author":"Spadaro","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"issue":"3","key":"10.1016\/j.cca.2012.05.007_bb0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00296-002-0267-y","article-title":"Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Rheumatol Int"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T19:56:59Z","timestamp":1687463819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898112002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":53,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0009898112002331"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2012.05.007","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}